miR-1291 Functions as a Potential Serum Biomarker for Bullous Pemphigoid

Table 2

Initial therapeutic regimens of the 45 BP patients.

Therapeutic regimens
Systemic prednisone (or equivalent) (mg/kg/day)	39
<0.5	6
0.5-0.75	19
>0.75	14
Oral nicotinamide and minocycline and topical halometasone	6